How much it can cost to develop a single drug. The MIT-founded startup ASG has a new biosensor that detects proteins in 15 minutes and could replace slow, pricey ELISA tests used in drug development. Faster tests mean cheaper bioprocessing, more efficient manufacturing and a chance for rare disease drugs that usually get shelved for being “not profitable enough.”
All tech. No filler.
Join 900,000+ people who stay ahead of the tech curve with The Current, delivered daily. No fluff, no BS.